Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136.
Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136
Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19165-19175. doi: 10.1073/pnas.1904563116. Epub 2019 Sep 4.
Accumulative aggregation of mutant Huntingtin (Htt) is a primary neuropathological hallmark of Huntington's disease (HD). Currently, mechanistic understanding of the cytotoxicity of mutant Htt aggregates remains limited, and neuroprotective strategies combating mutant Htt-induced neurodegeneration are lacking. Here, we show that in models of HD, neuronal compartment-specific accumulation of mutant Htt aggregates causes neurodegenerative phenotypes. In addition to the increase in the number and size, we discovered an age-dependent acquisition of thioflavin S, amyloid-like adhesive properties of mutant Htt aggregates and a concomitant progressive clustering of aggregates with mitochondria and synaptic proteins, indicating that the amyloid-like adhesive property underlies the neurotoxicity of mutant Htt aggregation. Importantly, nicotinamide mononucleotide adenylyltransferase (NMNAT), an evolutionarily conserved nicotinamide adenine dinucleotide (NAD) synthase and neuroprotective factor, significantly mitigates mutant Htt-induced neurodegeneration by reducing mutant Htt aggregation through promoting autophagic clearance. Additionally, Nmnat overexpression reduces progressive accumulation of amyloid-like Htt aggregates, neutralizes adhesiveness, and inhibits the clustering of mutant Htt with mitochondria and synaptic proteins, thereby restoring neuronal function. Conversely, partial loss of endogenous Nmnat exacerbates mutant Htt-induced neurodegeneration through enhancing mutant Htt aggregation and adhesive property. Finally, conditional expression of Nmnat after the onset of degenerative phenotypes significantly delays the progression of neurodegeneration, revealing the therapeutic potential of Nmnat-mediated neuroprotection at advanced stages of HD. Our study uncovers essential mechanistic insights to the neurotoxicity of mutant Htt aggregation and describes the molecular basis of Nmnat-mediated neuroprotection in HD.
突变亨廷顿蛋白(Htt)的累积聚集是亨廷顿病(HD)的主要神经病理学特征。目前,对突变 Htt 聚集物的细胞毒性的机制理解仍然有限,并且缺乏针对突变 Htt 诱导的神经退行性变的神经保护策略。在这里,我们表明在 HD 的模型中,神经元区室特异性积聚突变 Htt 聚集体导致神经退行性表型。除了数量和大小的增加外,我们还发现突变 Htt 聚集体的硫黄素 S、淀粉样粘性特性以及与线粒体和突触蛋白的伴随性进行性聚集具有年龄依赖性,表明淀粉样粘性特性是突变 Htt 聚集物的神经毒性的基础。重要的是,烟酰胺单核苷酸腺苷酰转移酶(NMNAT)是一种进化上保守的烟酰胺腺嘌呤二核苷酸(NAD)合酶和神经保护因子,通过促进自噬清除来显著减轻突变 Htt 诱导的神经退行性变,从而减少突变 Htt 聚集。此外,Nmnat 的过表达减少了淀粉样 Htt 聚集体的进行性积累,中和了粘性,并抑制了突变 Htt 与线粒体和突触蛋白的聚类,从而恢复了神经元功能。相反,内源性 Nmnat 的部分缺失通过增强突变 Htt 聚集和粘性特性加剧了突变 Htt 诱导的神经退行性变。最后,在退行性表型出现后条件表达 Nmnat 显著延迟了神经退行性变的进展,揭示了 Nmnat 介导的神经保护在 HD 的晚期阶段的治疗潜力。我们的研究揭示了突变 Htt 聚集物的神经毒性的基本机制见解,并描述了 Nmnat 介导的神经保护在 HD 中的分子基础。